Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Apr 21, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 23, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001703469-26-000002
Filed / recorded
Apr 23, 2026, 7:25 PM UTC
Added to OQRO
Oct 6, 2026, 4:40 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
BIO-RAD LABORATORIES, INC.
Issuer CIK
12208
Ticker
BIO BIO.B
Reporting person
Melinda Litherland Pei
Relationship
Director
Security
Restricted Stock Units
Table
Derivative (Table II)
Transaction date
Apr 21, 2026
Transaction code
A
Shares / units
369
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
369
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders.